Published in

American Association for Cancer Research, Cancer Discovery, 8(13), p. 1762-1764, 2023

DOI: 10.1158/2159-8290.cd-23-0534

Links

Tools

Export citation

Search in Google Scholar

Patient-Centric Approaches for Phase I Combination Trials Come on Stage

Journal article published in 2023 by Alberto Hernando-Calvo ORCID, Elena Garralda ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Summary:A disruptive clinical trial design allowed Drilon and colleagues to demonstrate proof of concept of the potential of PF-07284892 to overcome resistance mechanisms to targeted therapies in the clinic.See related article by Drilon et al., p. 1789 (7).